As of 2014, the Internal Neuromodulation market was estimated dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Depuy Synthes, Inc. (U.S.), Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc.
(PRWEB) March 28, 2015
This report studies the Asia-Pacific Internal Neuromodulation devices market for the forecast period between 2014 and 2019. The market is estimated to reach ~$573.3 million by 2019, at CAGR of 13.8% between 2014 and 2019.
Browse through the TOC of Asia-Pacific Internal Neuromodulation devices market for an analysis of industry trends and segments, with the help of various tables and figures.
The Asia-Pacific Internal Neuromodulation market is classified into five main modalities, Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, and Gastric Neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain, and others.
Similarly, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while the Vagus Nerve Stimulator comprises Epilepsy and other applications.
Early buyers will receive 10% customization on this report.
Several factors, such as growing public and private initiatives to increase awareness, rising incidences of neurological diseases, increasing demand for advanced technologies, government investments and rapid growth in aging population are driving the growth of the Internal Neuromodulation market. On the other hand, lack of trained professionals and unfavorable reimbursement scenario are the restricting factors for the market growth.
As of 2014, Japan is estimated to hold the largest share of the Asia-Pacific Internal Neuromodulation market, followed by China. However, the Indian market is projected to register the highest CAGR of 15.3% between 2014 and 2019. Several factors, including rising incidences of neurological disorder, increasing focus on adaption of advanced technologies. Also, the development of healthcare infrastructure is stimulating the growth of the internal neuromodulation market in the Asia-Pacific region.
Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Depuy Synthes, Inc. (U.S.), Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) are the leading players in the Asia-Pacific Internal Neuromodulation market.
Global Internal Neurostimulation Market Research Report
The Global Internal Neurostimulation Devices Market, is mainly driven by rapidly aging population and associated diseases like Alzheimer’s, epilepsy, spinal cord injury and Parkinson’s disease expected to grow at a CAGR of 11.8% in the next five years primarily due to technical advances and patient-friendly techniques such as minimally invasive and non-invasive. The Internal Neurostimulation market was $3903.2 million in 2013 and expected to reach $6828.8 million by 2018 at a CAGR of 11.8%.The Internal Neuromodulation market is the largest segment 87% of Overall Neurostimulation market
MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare Industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare Industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.